Hypoglycemic and Hypolipidemic Effects of Alcoholic Extract of Mimosa Catechu Bark in Alloxan Induced Diabetic Rats

Herbal medicine has been used for many years by different cultures around the world for the treatment of diabetes and hence the alcoholic bark extract of Mimosa catechu (AEMC) Wild plant was investigated for its possible antihyperglycemic effect in alloxan induced diabetic rats. The animals were made diabetic by intraperitoneal injection of alloxan monohydrate at a dose of 150mg/kg body weight. The alcoholic extract of Mimosa catechu, AEMC (250 and 500mg kg^-1) and the standard drug (Glibenclamide 0.5mg/kg) were administered orally. Control group of rats were administered 0.2ml of 10% acacia mucilage (vehicle). The effect of oral administration of AEMC for 7days on the levels of Serum glucose, total cholesterol, and triglycerides, HDL-cholesterol, LDL-cholesterol in normal and diabetic rats were evaluated and compared with that of standard antidiabetic drug, Glibenclamide. Oral administration of 250 and 500mg kg^-1 body wt of AEMC for 7 days exhibited a significant reduction in serum glucose, total cholesterol, triglycerides, LDLcholesterol and increase in HDL-cholesterol, Plasma insulin in alloxan induced diabetic rats. The antidiabetic effect of AEMC was similar to Glibenclamide. Hence our study reveals the antidiabetic and Hypolipidemic potential of Mimosa catechu bark and the study could be helpful to develop medicinal preparations for diabetes and related symptoms.